Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
726.50 GBX | +1.18% | -20.16% | -38.69% |
09-05 | Transcript : Indivior PLC Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 10:45 AM | |
09-04 | Indivior reports "disappointing" results for study with Aelis Farma | AN |
EPS & Dividend: Indivior PLC
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Rate of return | - | - | - | - | - | - | - | - |
EPS 2 | 0.9 | -1 | 1.35 | -0.38 | 0.01 | 0.97 | 1.853 | 2.82 |
Distribution rate | - | - | - | - | - | - | - | - |
Reference price 2 | 2.583 | 7.427 | 17.400 | 22.315 | 15.094 | 9.351 | 9.351 | 9.351 |
Nbr of stocks (in thousands) | 146,153 | 146,701 | 140,437 | 136,489 | 136,551 | 131,459 | - | - |
Announcement Date | 13/02/20 | 18/02/21 | 16/02/22 | 16/02/23 | 22/02/24 | - | - | - |
Past dividends: Indivior PLC
15/06/2016 | Final Payment 0.073 GBP |
16/09/2015 | Interim Payment 0.0208 GBP |
Upcoming events: Indivior PLC
30/10/2024 | Q3 2024 Earnings Release (Projected) |
12/02/2025 | Q4 2024 Earnings Release (Projected) |
23/04/2025 | Q1 2025 Earnings Release (Projected) |
23/07/2025 | Q2 2025 Earnings Release (Projected) |
Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
---|---|---|---|---|---|---|
-.--% | -.--% | 9.64x | -8.061000 | 1.02x | ||
+1.36% | +1.52% | 24.7x | 2.558 | 3.77x | ||
+1.81% | +1.89% | 24.95x | 2.000 | 2.8x | ||
+0.35% | +0.35% | 60.04x | 4.332 | 4.34x | ||
-.--% | -.--% | 109.64x | 21.68 | 14.55x | ||
+0.65% | +0.97% | 34.62x | 2.924 | 6.21x | ||
+17.58% | +20.02% | 11.38x | 1.058 | - | ||
- | - | 29.66x | 6.220 | - | ||
- | - | 107.17x | - | - | ||
- | - | - | - | - | ||
Average | +3.11% | +3.54% | 45.76x | 4.09 | 5.45x | |
Weighted average by Cap. | +1.53% | +1.70% | 32.24x | 3.52 | 4.30x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition